The Davis Companies (TDC) has developed a new research centre in West Cambridge, Massachusetts.
The Alewife Research Centre (ARC) will be located at 35 Cambridge Park Drive. Initiated in February 2017, it will provide laboratory space for life science and pharmaceutical companies.
Scheduled to be completed by mid-2018, the centre will enable more companies to contribute to Cambridge’s reputation as a prime centre for research and development (R&D).
Alewife Research Centre is being constructed next to Alewife subway station, which is nearby Kendall Square and Harvard Square. The area can be accessed via the MBTA Red Line subway and the Metro West suburbs via Route 2.
The ARC will be situated in a five-storey building with a total floor space of 223,000ft². It will feature flexible lab and R&D spaces, an employee lounge, conference and meeting areas, a fitness workout area with showers and lockers, and a bike room with secure storage.
In addition, the building will include a 29,000ft² penthouse to support the tenant roof-top equipment.
A grand lobby with a two-storey atrium and gathering spaces will be provided, as well as a service elevator with a capacity of 5,000lb running between the first floor main lobby and the penthouse.
The centre will also include a loading dock area with dock levers and feature concrete slab floors with a live load capacity up to 100 per ft². It will have a floor-to-floor height of 11ft on the first floor and 14ft 6in on the other floors. The column bay spacing will be 22ft 6in x 22ft 6in for the first floor and 22ft 6in x 45ft for floors two to five.
The laboratory in the ARC will feature air-handling units with pre-filters, final filters, and chilled and hot water coils. It will have a paring at a ratio of 1.5 spaces per 1,000ft².
Spagnolo Gisness & Associates (SGA) was awarded a contract to design the core, shell, and lobby elements of the research building. McNamara Salvia, VHB, and AHA Consulting Engineers were awarded the structural engineering services contract.
John Moriarty & Associates was awarded the general construction contract for the research facility. Ipswitch Bay Glass (IBG) was contracted to provide curtainwalls and windows for lab building.
Headquartered in Boston, The Davis Companies (TDC) is a real estate investment, development, and management firm. The company has invested more than $4bn in gross asset value through real estate equity, debt and fixed-income securities. It owns real estate portfolio of approximately 12 million ft² across the Eastern US.
Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The…
Merck announced the expansion of its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) production capabilities and capacity at…
Contract development and manufacturing organisation (CDMO) Sai Life Sciences inaugurated its new research and technology (R&T) centre in Hyderabad, India…